ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,829Medicare Part D Prescriptions Filled, Including Refills

Rank: 110 out of 1006

$726K Total Retail Price of All Prescriptions

Rank: 97 out of 1006

323 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 323 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 323 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 8,164 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
WARFARIN SODIUM 361 310 1 8
METOPROLOL TARTRATE 289 261 2 7
LEVOTHYROXINE SODIUM 284 226 3 2
FUROSEMIDE 277 257 4 6
SIMVASTATIN 230 200 5 1
LISINOPRIL 207 177 6 3
OMEPRAZOLE 173 139 7 9
DONEPEZIL HCL 155 155 8 17
CARVEDILOL 155 150 8 36
AMLODIPINE BESYLATE 154 145 10 4
ESCITALOPRAM OXALATE 148 137 11 27
CYMBALTA 148 86 11 41
ZOLPIDEM TARTRATE 144 130 13 14
DIOVAN 140 122 14 16
MIRTAZAPINE 139 128 15 26
TRAMADOL HCL 135 116 16 35
SERTRALINE HCL 125 114 17 19
ATENOLOL 121 114 18 13
TRAZODONE HCL 120 92 19 21
ATORVASTATIN CALCIUM 120 117 19 5
LIDODERM 119 113 21 66
NAMENDA 118 118 22 34
LANTUS 105 79 23 43
METOPROLOL SUCCINATE 105 77 23 12
MELOXICAM 98 91 25 67
HYDROCODONE-ACETAMINOPHEN 98 52 S3 25 25
CLOPIDOGREL 94 81 27 46
CITALOPRAM HBR 92 82 28 24
DIGOXIN 91 91 29 52
POTASSIUM CHLORIDE 86 86 30 30
TRIAMCINOLONE ACETONIDE 81 75 31 135
METFORMIN HCL 81 79 31 10
PREDNISONE 78 62 33 33
GABAPENTIN 78 61 33 20
ADVAIR DISKUS 78 72 33 37
NOVOLOG 75 72 36 94
SPIRONOLACTONE 74 71 37 71
TAMSULOSIN HCL 69 47 38 23
OXYBUTYNIN CHLORIDE ER 64 64 39 92
ROPINIROLE HCL 62 58 40 154
FENTANYL 60 39 S2 41 74
EXELON 60 50 41 99
ISOSORBIDE MONONITRATE ER 59 56 43 59
NEXIUM 59 33 43 28
LEXAPRO 58 56 45 103
LAMOTRIGINE 58 37 45 119
BACLOFEN 57 14 47 95
QUETIAPINE FUMARATE 56 36 48 45
PLAVIX 52 42 49 61
HYDROXYZINE HCL 52 50 R 49 189
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 12, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.